title: [Quality of life of patients with prostatic cancer under hormonal therapy].
abstract: Our experience of kalumide (bikalutamide) administration in patients with prostatic cancer agrees with the data of other investigators on a good effect of the drug on quality of life of patients with prostatic cancer.
authors.forename: Iu G
authors.initials: IuG
authors.lastname: Aliaev
authors.forename: E G
authors.initials: EG
authors.lastname: Aslamazov
authors.forename: Iu L
authors.initials: IuL
authors.lastname: Demidko
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary; D018572:Disease-Free Survival; D006801:Humans; D017567:Karnofsky Performance Status; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D011788:Quality of Life
chemical_list: D018931:Antineoplastic Agents, Hormonal